Artur Płonowski

Stability of cytotoxic luteinizing hormone-releasing hormone conjugate (AN-152) containing doxorubicin 14- <i>O</i> -hemiglutarate in mouse and human serum <i>in vitro:</i> Implications for the design of preclinical studies

Attila Nagy, Artur Płonowski, Andrew V. Schally · Proceedings of the National Academy of Sciences · 2000 · 88 citations

Medicine, Medicinal Chemistry, Pharmacology +15

Human renal cell carcinoma expresses distinct binding sites for growth hormone-releasing hormone

Gábor Halmos, Andrew V. Schally, József L. Varga et al. · Proceedings of the National Academy of Sciences · 2000 · 86 citations · Full text

Medicine, Oncology, Pharmacology +17

Potentiation of the inhibitory effect of growth hormone-releasing hormone antagonists on PC-3 human prostate cancer by bombesin antagonists indicative of interference with both IGF and EGF pathways

Artur Płonowski, Andrew V. Schally, József L. Varga et al. · The Prostate · 2000 · 64 citations

Medicine, Oncology, Pharmacology +17

High Expression of Somatostatin Receptors and Messenger Ribonucleic Acid for Its Receptor Subtypes in Organ-Confined and Locally Advanced Human Prostate Cancers1

Gábor Halmos, Andrew V. Schally, Baodong Sun et al. · The Journal of Clinical Endocrinology & Metabolism · 2000 · 63 citations · Full text

Medicine, Molecular Biology, Oncology +14

in vivo inhibition of PC-3 human androgen-independent prostate cancer by a targeted cytotoxic bombesin analogue, AN-215

Artur Płonowski, Attila Nagy, Andrew V. Schally et al. · International Journal of Cancer · 2000 · 58 citations

Medicine, Oncology, Pharmacology +16